| Dr Colleen Mary Crandell, DO | |
|
200 Plaza Dr, Suite B, Vestal, NY 13850-3680 | |
| (607) 729-2777 | |
| Not Available |
| Full Name | Dr Colleen Mary Crandell |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 20 Years |
| Location | 200 Plaza Dr, Vestal, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144269176 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 227706 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lourdes Hospital | Binghamton, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Schweiger Dermatology Pllc | 5991947160 | 178 |
News Archive
A new book looking at the extraordinary progress being made to fight cancer titled Why Millions Survive Cancer has been written by Dr Lauren Pecorino, Principal Lecturer in Cancer Biology at the University of Greenwich.
Mutations in RAS proteins initiate many of the most aggressive tumors, and the search for pharmacological inhibitors of these proteins has become a priority in the battle against cancer. Michail Steklov, Francesca Baietti, and colleagues from the Anna Sablina lab identified LZTR1 as an evolutionarily conserved component of the RAS pathway.
The Ninth Annual Controversies and Advances in Treatment of Cardiovascular Disease continuing medical education conference will feature several discussions and presentations on how healthcare reform could affect cardiovascular disease patients' diagnosis, treatment and outcome.
Pressure BioSciences, Inc., a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced the commercial release of the PCT-HD system.
Boehringer Ingelheim and Eli Lilly and Company announce new data that reinforce the efficacy and tolerability of linagliptin in people with Type 2 Diabetes and liver disease, as well as Asian people with T2D aged 65 years or older.
› Verified 6 days ago
| Entity Name | Southern Tier Dermatology & Aesthetics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275589558 PECOS PAC ID: 7214931815 Enrollment ID: O20060913000493 |
News Archive
A new book looking at the extraordinary progress being made to fight cancer titled Why Millions Survive Cancer has been written by Dr Lauren Pecorino, Principal Lecturer in Cancer Biology at the University of Greenwich.
Mutations in RAS proteins initiate many of the most aggressive tumors, and the search for pharmacological inhibitors of these proteins has become a priority in the battle against cancer. Michail Steklov, Francesca Baietti, and colleagues from the Anna Sablina lab identified LZTR1 as an evolutionarily conserved component of the RAS pathway.
The Ninth Annual Controversies and Advances in Treatment of Cardiovascular Disease continuing medical education conference will feature several discussions and presentations on how healthcare reform could affect cardiovascular disease patients' diagnosis, treatment and outcome.
Pressure BioSciences, Inc., a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced the commercial release of the PCT-HD system.
Boehringer Ingelheim and Eli Lilly and Company announce new data that reinforce the efficacy and tolerability of linagliptin in people with Type 2 Diabetes and liver disease, as well as Asian people with T2D aged 65 years or older.
› Verified 6 days ago
| Entity Name | Schweiger Dermatology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831438662 PECOS PAC ID: 5991947160 Enrollment ID: O20130819000251 |
News Archive
A new book looking at the extraordinary progress being made to fight cancer titled Why Millions Survive Cancer has been written by Dr Lauren Pecorino, Principal Lecturer in Cancer Biology at the University of Greenwich.
Mutations in RAS proteins initiate many of the most aggressive tumors, and the search for pharmacological inhibitors of these proteins has become a priority in the battle against cancer. Michail Steklov, Francesca Baietti, and colleagues from the Anna Sablina lab identified LZTR1 as an evolutionarily conserved component of the RAS pathway.
The Ninth Annual Controversies and Advances in Treatment of Cardiovascular Disease continuing medical education conference will feature several discussions and presentations on how healthcare reform could affect cardiovascular disease patients' diagnosis, treatment and outcome.
Pressure BioSciences, Inc., a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced the commercial release of the PCT-HD system.
Boehringer Ingelheim and Eli Lilly and Company announce new data that reinforce the efficacy and tolerability of linagliptin in people with Type 2 Diabetes and liver disease, as well as Asian people with T2D aged 65 years or older.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Colleen Mary Crandell, DO 25 Deborah Dr, Johnson City, NY 13790-5102 Ph: (607) 729-0779 | Dr Colleen Mary Crandell, DO 200 Plaza Dr, Suite B, Vestal, NY 13850-3680 Ph: (607) 729-2777 |
News Archive
A new book looking at the extraordinary progress being made to fight cancer titled Why Millions Survive Cancer has been written by Dr Lauren Pecorino, Principal Lecturer in Cancer Biology at the University of Greenwich.
Mutations in RAS proteins initiate many of the most aggressive tumors, and the search for pharmacological inhibitors of these proteins has become a priority in the battle against cancer. Michail Steklov, Francesca Baietti, and colleagues from the Anna Sablina lab identified LZTR1 as an evolutionarily conserved component of the RAS pathway.
The Ninth Annual Controversies and Advances in Treatment of Cardiovascular Disease continuing medical education conference will feature several discussions and presentations on how healthcare reform could affect cardiovascular disease patients' diagnosis, treatment and outcome.
Pressure BioSciences, Inc., a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced the commercial release of the PCT-HD system.
Boehringer Ingelheim and Eli Lilly and Company announce new data that reinforce the efficacy and tolerability of linagliptin in people with Type 2 Diabetes and liver disease, as well as Asian people with T2D aged 65 years or older.
› Verified 6 days ago
Manisha Manmohan, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 200 Front St, Vestal, NY 13850 Phone: 607-658-1003 Fax: 607-658-1006 | |
Romeo Morales, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 200 Front St, Vestal, NY 13850 Phone: 607-658-1003 Fax: 607-658-1006 | |
Shelly Rivas, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3101 Shippers Rd Ste 102, Vestal, NY 13850 Phone: 607-251-2100 | |
Ayyaz M Shah, DO Dermatology Medicare: Accepting Medicare Assignments Practice Location: 200 Front St, Vestal, NY 13850 Phone: 607-658-1003 Fax: 607-658-1006 | |
Dr. Uzoma Oranu, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 200 Front St, Vestal, NY 13850 Phone: 607-658-1003 Fax: 607-658-1006 | |
Dr. Genadij Sienkiewicz, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 200 Front St, Vestal, NY 13850 Phone: 607-658-1003 Fax: 607-658-1006 |